Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Microneedles: Report describes progress in new technology for painless drug delivery

18.11.2003


New fabrication results



The paper describes research at the Georgia Institute of Technology on fabricating hollow and solid microneedles in a variety of sizes and shapes from metals, biodegradable polymers, silicon and glass. It also reports on testing with cadaver skin and animals that demonstrates the ability of the micron-scale needles to deliver proteins, nanoparticles, and both small and large molecules through the skin.

"We’ve opened up the potential use of microneedles for delivering a broad range of therapeutics," said Mark Prausnitz, a professor in Georgia Tech’s School of Chemical and Biomolecular Engineering and principal investigator for the project. "Fabricating both hollow and solid microneedles in a variety of shapes, sizes and materials allows us to deliver large molecules with significant therapeutic interest such as insulin, proteins produced by the biotechnology industry, and nanoparticles that could encapsulate a drug or demonstrate the ability to deliver a virus for vaccinations."


Georgia Tech’s development of microneedles began in the late 1990s with microfabrication of solid needles made from silicon, using microlithography and etching technologies originally developed for the microelectronics industry. The researchers produced arrays of up to 400 needles designed to punch holes in the outer layer of skin to increase its permeability to small molecules applied with patches.

That work has broadened to include both solid and hollow microneedles in a broad range of shapes with feature sizes from one to 1,000 microns. Prausnitz and his research team have fabricated microneedle arrays from metal and polymer materials that have sufficient strength to reliably penetrate the skin without breakage.

Moving beyond the original – and complex – microelectronics-based fabrication techniques, the researchers have developed multiple manufacturing processes suitable for the mass production of microneedles from inexpensive metal and polymer materials. By making molds of their silicon needles, for instance, the research team has produced arrays of identical metal or polymer microneedles using a modified form of injection molding that can readily be adapted to industrial mass production.

Molds were also made without the need for creating silicon needles to use as masters. Metal microneedles were produced through electrodeposition onto laser-drilled polymer molds, while glass microneedle masters were fabricated using conventional drawn-glass micropipette techniques.

The broad range of sizes, shapes and materials will permit production of microneedle arrays customized for the type and volume of drug to be delivered, the time period of use, and most importantly, minimizing pain.

"There are trade offs between getting needles to go into the skin easily, getting drugs to deliver easily and making needles that don’t hurt," Prausnitz said. "Not every application will need a different needle, but there will probably be classes of applications that will benefit from different needle designs."

Among the potential applications are:
  • Arrays of hollow needles could be used to continuously carry drugs into the body using simple diffusion or a pump system;

  • Hollow microneedles could be used to remove fluid from the body for analysis – such as blood glucose measurements – and to then supply microliter volumes of insulin or other drug as required;

  • Microneedles may prove useful for immunization programs in developing countries or for the mass vaccination or administration of antidotes in bioterrorism incidents because they could be applied by persons with minimal medical training, and

  • Very small microneedles could provide highly targeted drug administration to individual cells.

Microneedles are expected to be less painful than conventional hypodermic needles because they are too small to significantly stimulate nerve endings, Prausnitz said. Small-scale studies so far have confirmed that expectation, and additional pain studies are planned. The safety and effectiveness of microneedles must still be proven in humans before they can receive Food & Drug Administration approval for clinical use.

Before microneedles find widespread use, the researchers must perfect the techniques for optimally inserting them into the skin, and complete the integration of microneedles into a full drug delivery system. The need to minimize variability in needle insertion is being addressed in part by development of an applicator device that would be part of the delivery system.

Several companies are pursuing development of microneedles, including some that are conducting clinical trials.

"There is an aggressive movement toward bringing microneedles to the market," Prausnitz said. "We’ve shown that microneedles can serve as a hybrid drug delivery system, combining the advantages of conventional needles – which deliver drugs easily – with transdermal patches that are more patient-friendly. I expect that within the next five years, a microneedle device will become available for clinical use."


Beyond Prausnitz, the research team includes Devin McAllister, Ping Wang, Shawn Davis, Jung-Hwan Park, Paul Canatella and Mark Allen. The research has been sponsored by the National Institutes of Health (NIH), the National Science Foundation (NSF), the American Diabetes Association and the Defense Advanced Research Projects Agency (DARPA).

John Toon | EurekAlert!
Further information:
http://gtresearchnews.gatech.edu/

More articles from Process Engineering:

nachricht New manufacturing process for SiC power devices opens market to more competition
14.09.2017 | North Carolina State University

nachricht Quick, Precise, but not Cold
17.05.2017 | Fraunhofer-Institut für Lasertechnik ILT

All articles from Process Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The fastest light-driven current source

Controlling electronic current is essential to modern electronics, as data and signals are transferred by streams of electrons which are controlled at high speed. Demands on transmission speeds are also increasing as technology develops. Scientists from the Chair of Laser Physics and the Chair of Applied Physics at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have succeeded in switching on a current with a desired direction in graphene using a single laser pulse within a femtosecond ¬¬ – a femtosecond corresponds to the millionth part of a billionth of a second. This is more than a thousand times faster compared to the most efficient transistors today.

Graphene is up to the job

Im Focus: LaserTAB: More efficient and precise contacts thanks to human-robot collaboration

At the productronica trade fair in Munich this November, the Fraunhofer Institute for Laser Technology ILT will be presenting Laser-Based Tape-Automated Bonding, LaserTAB for short. The experts from Aachen will be demonstrating how new battery cells and power electronics can be micro-welded more efficiently and precisely than ever before thanks to new optics and robot support.

Fraunhofer ILT from Aachen relies on a clever combination of robotics and a laser scanner with new optics as well as process monitoring, which it has developed...

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Creative use of noise brings bio-inspired electronic improvement

26.09.2017 | Physics and Astronomy

Filter may be a match for fracking water

26.09.2017 | Power and Electrical Engineering

Bacterial Nanosized Speargun Works Like a Power Drill

26.09.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>